AI speeds up the R&D for ALS treatment

AI speeds up the R&D for ALS treatment

by | Apr 21, 2021 | Press Releases

Today we speak to Dr. Vang Le-Quy at Aalborg University, about how his team is collaborating with Dr. John Nieland, 2N Pharma Co-Founder and his research group at Aalborg University’s Health Science and Technology Department, in the search for a cure to Amyotrophic...
The 2N Pharma Team – Michael Sloth Trabjerg

The 2N Pharma Team – Michael Sloth Trabjerg

by | Mar 16, 2021 | Press Releases

Last month, Michael Sloth Trabjerg, Scientific Adviser for 2N Pharma successfully completed the defence of his PhD research into lipid metabolism dysfunction in Amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) at Aalborg University. In...